Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Cancer Biology & Therapy|September 7, 2010
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinomaAlvarez Hector, Elizabeth A Montgomery, Collins Karikari, et al.
Nature Communications|December 22, 2018
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastomaGary L Gallia, Ming Zhang, Yi Ning, et al.
Nature Communications|May 27, 2018
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastomaBill H Diplas, Xujun He, Jacqueline A Brosnan-Cashman, et al.
The American Journal of Pathology|September 6, 2011
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypesChristopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, et al.
Science (New York, N.Y.)|July 2, 2011
Altered telomeres in tumors with ATRX and DAXX mutationsChristopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, et al.
Oncotarget|July 10, 2018
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancerKarim Boudadi, Daniel L Suzman, Valsamo Anagnostou, et al.
Oncotarget|August 8, 2012
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomasYuchen Jiao, Patrick J Killela, Zachary J Reitman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2011
Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cellsHiroyuki Konishi, Morassa Mohseni, Akina Tamaki, et al.
Seminars in Cancer Biology|April 15, 2015
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutritionLynnette R Ferguson, Helen Chen, Andrew R Collins, et al.
Pageof 13